# Mosaic Co: financial statements, quarterly

MOS · NYSE · CIK 1285785 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mos.md) · [Financials](/companies/mos/financials.md) · [Filings](/companies/mos/filings.md) · [Insiders](/companies/mos/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mos/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,548](/filings/0001618034-24-000019.md) | [3,150 d](/filings/0001285785-26-000017.md) | [2,679](/filings/0001618034-25-000005.md) | [2,817](/filings/0001628280-25-038265.md) | [2,811](/filings/0001628280-25-049494.md) | [2,816 d](/filings/0001285785-26-000017.md) | [2,621](/filings/0001285785-26-000067.md) | [3,006](/filings/0001285785-26-000112.md) | [3,452](/filings/0001628280-25-049494.md) | [2,974 d](/filings/0001285785-26-000017.md) | [2,998](/filings/0001285785-26-000067.md) | [2,824](/filings/0001285785-26-000112.md) |
| Cost of revenue | $m | [3,139](/filings/0001618034-24-000019.md) | [2,590 d](/filings/0001285785-26-000017.md) | [2,280](/filings/0001618034-25-000005.md) | [2,423](/filings/0001628280-25-038265.md) | [2,394](/filings/0001628280-25-049494.md) | [2,514 d](/filings/0001285785-26-000017.md) | [2,133](/filings/0001285785-26-000067.md) | [2,487](/filings/0001285785-26-000112.md) | [2,900](/filings/0001628280-25-049494.md) | [2,631 d](/filings/0001285785-26-000017.md) | [2,762](/filings/0001285785-26-000067.md) | [2,609](/filings/0001285785-26-000112.md) |
| Gross profit | $m | [410](/filings/0001618034-24-000019.md) | [560 d](/filings/0001285785-26-000017.md) | [399](/filings/0001618034-25-000005.md) | [394](/filings/0001628280-25-038265.md) | [417](/filings/0001628280-25-049494.md) | [302 d](/filings/0001285785-26-000017.md) | [488](/filings/0001285785-26-000067.md) | [519](/filings/0001285785-26-000112.md) | [552](/filings/0001628280-25-049494.md) | [343 d](/filings/0001285785-26-000017.md) | [236](/filings/0001285785-26-000067.md) | [215](/filings/0001285785-26-000112.md) |
| Selling, general and administrative | $m | [120](/filings/0001618034-24-000019.md) | [123 d](/filings/0001285785-26-000017.md) | [107](/filings/0001618034-25-000005.md) | [128](/filings/0001628280-25-038265.md) | [148](/filings/0001628280-25-049494.md) | [114 d](/filings/0001285785-26-000017.md) | [123](/filings/0001285785-26-000067.md) | [167](/filings/0001285785-26-000112.md) | [126](/filings/0001628280-25-049494.md) | [119 d](/filings/0001285785-26-000017.md) | [136](/filings/0001285785-26-000067.md) | [132](/filings/0001285785-26-000112.md) |
| Operating income | $m | [146](/filings/0001618034-24-000019.md) | [279 d](/filings/0001285785-26-000017.md) | [173](/filings/0001618034-25-000005.md) | [233](/filings/0001628280-25-038265.md) | [115](/filings/0001628280-25-049494.md) | [99.9 d](/filings/0001285785-26-000017.md) | [339](/filings/0001285785-26-000067.md) | [244](/filings/0001285785-26-000112.md) | [340](/filings/0001628280-25-049494.md) | [(101) d](/filings/0001285785-26-000017.md) | [(373)](/filings/0001285785-26-000067.md) | [(35.5)](/filings/0001285785-26-000112.md) |
| Income tax | $m | [(5.9)](/filings/0001618034-24-000019.md) | [(43.8) d](/filings/0001285785-26-000017.md) | [6.2](/filings/0001618034-25-000005.md) | [98.7](/filings/0001628280-25-038265.md) | [48.0](/filings/0001628280-25-049494.md) | [33.8 d](/filings/0001285785-26-000017.md) | [63.3](/filings/0001285785-26-000067.md) | [146](/filings/0001285785-26-000112.md) | [176](/filings/0001628280-25-049494.md) | [255 d](/filings/0001285785-26-000017.md) | [(31.0)](/filings/0001285785-26-000067.md) | [(33.8)](/filings/0001285785-26-000112.md) |
| Net income | $m | [(4.2)](/filings/0001618034-24-000019.md) | [365 d](/filings/0001285785-26-000017.md) | [45.2](/filings/0001618034-25-000005.md) | [(162)](/filings/0001628280-25-038265.md) | [122](/filings/0001628280-25-049494.md) | [169 d](/filings/0001285785-26-000017.md) | [238](/filings/0001285785-26-000067.md) | [411](/filings/0001285785-26-000112.md) | [411](/filings/0001628280-25-049494.md) | [(520) d](/filings/0001285785-26-000017.md) | [(258)](/filings/0001285785-26-000067.md) | [(273)](/filings/0001285785-26-000112.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001618034-24-000019.md) | not reported | [0.14](/filings/0001618034-25-000005.md) | [(0.50)](/filings/0001628280-25-038265.md) | [0.38](/filings/0001628280-25-049494.md) | not reported | [0.75](/filings/0001285785-26-000067.md) | [1.29](/filings/0001285785-26-000112.md) | [1.29](/filings/0001628280-25-049494.md) | not reported | [(0.81)](/filings/0001285785-26-000067.md) | [(0.86)](/filings/0001285785-26-000112.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001618034-24-000019.md) | not reported | [0.14](/filings/0001618034-25-000005.md) | [(0.50)](/filings/0001628280-25-038265.md) | [0.38](/filings/0001628280-25-049494.md) | not reported | [0.75](/filings/0001285785-26-000067.md) | [1.29](/filings/0001285785-26-000112.md) | [1.30](/filings/0001628280-25-049494.md) | not reported | [(0.81)](/filings/0001285785-26-000067.md) | [(0.86)](/filings/0001285785-26-000112.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001618034-24-000019.md) | [0.3](/filings/0001285785-26-000017.md) | [0.3](/filings/0001618034-25-000005.md) | [0.3](/filings/0001628280-25-038265.md) | [0.3](/filings/0001628280-25-049494.md) | [0.3](/filings/0001285785-26-000017.md) | [0.3](/filings/0001285785-26-000067.md) | [0.3](/filings/0001285785-26-000112.md) | [0.2](/filings/0001628280-25-049494.md) | [0.3](/filings/0001285785-26-000112.md) | [0.3](/filings/0001285785-26-000067.md) | [0.3](/filings/0001285785-26-000112.md) |
| Current assets | $bn | [5.2](/filings/0001618034-23-000019.md) | [4.7](/filings/0001618034-25-000003.md) | [4.7](/filings/0001618034-24-000006.md) | [4.8](/filings/0001618034-24-000013.md) | [5.0](/filings/0001618034-24-000019.md) | [4.5](/filings/0001285785-26-000017.md) | [4.6](/filings/0001618034-25-000005.md) | [5.0](/filings/0001628280-25-038265.md) | [5.1](/filings/0001628280-25-049494.md) | [5.2](/filings/0001285785-26-000112.md) | [5.3](/filings/0001285785-26-000067.md) | [5.4](/filings/0001285785-26-000112.md) |
| Total assets | $bn | [22.7](/filings/0001618034-23-000019.md) | [23.0](/filings/0001285785-26-000017.md) | [22.9](/filings/0001618034-24-000006.md) | [22.6](/filings/0001618034-24-000013.md) | [23.3](/filings/0001618034-24-000019.md) | [22.9](/filings/0001285785-26-000017.md) | [23.2](/filings/0001618034-25-000005.md) | [24.3](/filings/0001628280-25-038265.md) | [24.7](/filings/0001628280-25-049494.md) | [24.5](/filings/0001285785-26-000112.md) | [24.6](/filings/0001285785-26-000067.md) | [24.6](/filings/0001285785-26-000112.md) |
| Current liabilities | $bn | [4.7](/filings/0001618034-23-000019.md) | [3.9](/filings/0001618034-25-000003.md) | [4.0](/filings/0001618034-24-000006.md) | [4.1](/filings/0001618034-24-000013.md) | [4.2](/filings/0001618034-24-000019.md) | [4.2](/filings/0001285785-26-000017.md) | [4.1](/filings/0001618034-25-000005.md) | [4.4](/filings/0001628280-25-038265.md) | [4.4](/filings/0001628280-25-049494.md) | [4.0](/filings/0001285785-26-000112.md) | [4.3](/filings/0001285785-26-000067.md) | [4.1](/filings/0001285785-26-000112.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | [0.4](/filings/0001618034-25-000003.md) | not reported | not reported | not reported | [0.8](/filings/0001285785-26-000017.md) | not reported | not reported | not reported | [0.8](/filings/0001285785-26-000017.md) | not reported | not reported |
| Shareholders' equity | $bn | [12.1](/filings/0001618034-23-000019.md) | [12.3](/filings/0001618034-25-000003.md) | [12.0](/filings/0001618034-24-000006.md) | [11.7](/filings/0001618034-24-000013.md) | [11.8](/filings/0001618034-24-000019.md) | [11.5](/filings/0001285785-26-000017.md) | [11.8](/filings/0001618034-25-000005.md) | [12.4](/filings/0001628280-25-038265.md) | [12.8](/filings/0001628280-25-049494.md) | [12.1](/filings/0001285785-26-000112.md) | [11.8](/filings/0001285785-26-000067.md) | [11.5](/filings/0001285785-26-000112.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [647 d](/filings/0001618034-24-000019.md) | [538 d](/filings/0001285785-26-000017.md) | [(80.0)](/filings/0001618034-25-000005.md) | [847 d](/filings/0001628280-25-038265.md) | [313 d](/filings/0001628280-25-049494.md) | [219 d](/filings/0001285785-26-000017.md) | [42.9](/filings/0001285785-26-000067.md) | [610 d](/filings/0001285785-26-000112.md) | [229 d](/filings/0001628280-25-049494.md) | [(56.1) d](/filings/0001285785-26-000017.md) | [104](/filings/0001285785-26-000067.md) | [167 d](/filings/0001285785-26-000112.md) |
| Capital expenditure | $m | [412](/filings/0001618034-23-000019.md) | [359 d](/filings/0001285785-26-000017.md) | [383](/filings/0001618034-25-000005.md) | [334 d](/filings/0001628280-25-038265.md) | [241 d](/filings/0001628280-25-049494.md) | [294 d](/filings/0001285785-26-000017.md) | [341](/filings/0001285785-26-000067.md) | [305 d](/filings/0001285785-26-000112.md) | [364 d](/filings/0001628280-25-049494.md) | [350 d](/filings/0001285785-26-000017.md) | [357](/filings/0001285785-26-000067.md) | [320 d](/filings/0001285785-26-000112.md) |
| Dividends paid | $m | [66.4 d](/filings/0001618034-24-000019.md) | [65.1 d](/filings/0001285785-26-000017.md) | [69.7](/filings/0001618034-25-000005.md) | [67.7 d](/filings/0001628280-25-038265.md) | [66.8 d](/filings/0001628280-25-049494.md) | [66.5 d](/filings/0001285785-26-000017.md) | [70.9](/filings/0001285785-26-000067.md) | [70.1 d](/filings/0001285785-26-000112.md) | [69.5 d](/filings/0001628280-25-049494.md) | [69.9 d](/filings/0001285785-26-000017.md) | [70.8](/filings/0001285785-26-000067.md) | [69.9 d](/filings/0001285785-26-000112.md) |
| Share repurchases | $m | [150 d](/filings/0001618034-24-000019.md) | [150 d](/filings/0001285785-26-000017.md) | [108](/filings/0001618034-25-000005.md) | [52.0 d](/filings/0001628280-25-038265.md) | [50.0 d](/filings/0001628280-25-049494.md) | [25.0 d](/filings/0001285785-26-000017.md) | [0.0](/filings/0001618034-25-000005.md) | [0.0 d](/filings/0001628280-25-038265.md) | [0.0 d](/filings/0001628280-25-049494.md) | [0.0 d](/filings/0001285785-26-000017.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [348](/filings/0001618034-23-000019.md) | [339](/filings/0001618034-24-000006.md) | [334](/filings/0001618034-24-000013.md) | [332](/filings/0001618034-24-000019.md) | [324](/filings/0001618034-25-000005.md) | [321](/filings/0001628280-25-038265.md) | [319](/filings/0001628280-25-049494.md) | [318](/filings/0001285785-26-000067.md) | [319](/filings/0001285785-26-000112.md) | [319](/filings/0001628280-25-049494.md) | [318](/filings/0001285785-26-000067.md) | [318](/filings/0001285785-26-000112.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 317,895,646 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001285785-26-000112.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.